
Anna Pagonakis
Examiner (ID: 2415, Phone: (571)270-3505 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | OPET, 1614, 1609, 6221, 1628, 4173 |
| Total Applications | 1252 |
| Issued Applications | 445 |
| Pending Applications | 87 |
| Abandoned Applications | 723 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6292433
[patent_doc_number] => 20100239552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'Combination Therapies for Treating Metabolic Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/724756
[patent_app_country] => US
[patent_app_date] => 2010-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 48200
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20100239552.pdf
[firstpage_image] =>[orig_patent_app_number] => 12724756
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/724756 | Combination Therapies for Treating Metabolic Disorders | Mar 15, 2010 | Abandoned |
Array
(
[id] => 10168166
[patent_doc_number] => 09198857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-01
[patent_title] => 'Growth promotion of animals by simultaneous release of steroid compounds from a device'
[patent_app_type] => utility
[patent_app_number] => 13/256286
[patent_app_country] => US
[patent_app_date] => 2010-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6421
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256286
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/256286 | Growth promotion of animals by simultaneous release of steroid compounds from a device | Mar 14, 2010 | Issued |
Array
(
[id] => 6448205
[patent_doc_number] => 20100144886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'METHOD FOR TREATING PULMONARY ARTERIAL HYPERTENSION'
[patent_app_type] => utility
[patent_app_number] => 12/710133
[patent_app_country] => US
[patent_app_date] => 2010-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13482
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144886.pdf
[firstpage_image] =>[orig_patent_app_number] => 12710133
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/710133 | METHOD FOR TREATING PULMONARY ARTERIAL HYPERTENSION | Feb 21, 2010 | Abandoned |
Array
(
[id] => 6431049
[patent_doc_number] => 20100143366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'ANTITUMOR AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/707914
[patent_app_country] => US
[patent_app_date] => 2010-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5086
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143366.pdf
[firstpage_image] =>[orig_patent_app_number] => 12707914
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/707914 | ANTITUMOR AGENT | Feb 17, 2010 | Abandoned |
Array
(
[id] => 7651885
[patent_doc_number] => 20110301154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'SIGMA RECEPTORS LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES, OVER CELLULAR MECHANISMS, EXHIBITING PROTOTYPICAL CYTOPROTECTIVE AND ALSO ANTICANCER ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/201271
[patent_app_country] => US
[patent_app_date] => 2010-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 1652
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301154.pdf
[firstpage_image] =>[orig_patent_app_number] => 13201271
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201271 | SIGMA RECEPTORS LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES, OVER CELLULAR MECHANISMS, EXHIBITING PROTOTYPICAL CYTOPROTECTIVE AND ALSO ANTICANCER ACTIVITY | Feb 16, 2010 | Abandoned |
Array
(
[id] => 7670100
[patent_doc_number] => 20110319369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'COMBINATION OF A 17 ALPHA-HYDROXYLASE/C17, 20-LYASE INHIBITOR WITH AN ADDITIONAL THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/146001
[patent_app_country] => US
[patent_app_date] => 2010-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11752
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13146001
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/146001 | COMBINATION OF A 17 ALPHA-HYDROXYLASE/C17, 20-LYASE INHIBITOR WITH AN ADDITIONAL THERAPEUTIC AGENT | Feb 4, 2010 | Abandoned |
Array
(
[id] => 7586317
[patent_doc_number] => 20110280827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL MALIGNANCIES'
[patent_app_type] => utility
[patent_app_number] => 13/146247
[patent_app_country] => US
[patent_app_date] => 2010-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11933
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20110280827.pdf
[firstpage_image] =>[orig_patent_app_number] => 13146247
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/146247 | METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL MALIGNANCIES | Jan 27, 2010 | Abandoned |
Array
(
[id] => 6520998
[patent_doc_number] => 20100203164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'Therapeutic Treatment of Cancer and Dysplasia of the Cervix or Vagina Using Estrogen Antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/693850
[patent_app_country] => US
[patent_app_date] => 2010-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9339
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203164.pdf
[firstpage_image] =>[orig_patent_app_number] => 12693850
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/693850 | Therapeutic treatment of cancer and dysplasia of the cervix or vagina using estrogen antagonists | Jan 25, 2010 | Issued |
Array
(
[id] => 6546544
[patent_doc_number] => 20100222312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF ASTHMA'
[patent_app_type] => utility
[patent_app_number] => 12/693565
[patent_app_country] => US
[patent_app_date] => 2010-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7306
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20100222312.pdf
[firstpage_image] =>[orig_patent_app_number] => 12693565
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/693565 | DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF ASTHMA | Jan 25, 2010 | Abandoned |
Array
(
[id] => 7683660
[patent_doc_number] => 20100240751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'Methods'
[patent_app_type] => utility
[patent_app_number] => 12/657301
[patent_app_country] => US
[patent_app_date] => 2010-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12335
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240751.pdf
[firstpage_image] =>[orig_patent_app_number] => 12657301
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/657301 | Methods | Jan 18, 2010 | Abandoned |
Array
(
[id] => 8173665
[patent_doc_number] => 20120108559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'RECEPTOR ACTIVATOR OF THE RANK RECEPTOR COMPLEX INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 13/144568
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3151
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108559.pdf
[firstpage_image] =>[orig_patent_app_number] => 13144568
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/144568 | RECEPTOR ACTIVATOR OF THE RANK RECEPTOR COMPLEX INHIBITOR | Jan 6, 2010 | Abandoned |
Array
(
[id] => 7657336
[patent_doc_number] => 20110306605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'COUMARIN-BASED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER\'S DISEASE AND CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/140791
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 38291
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306605.pdf
[firstpage_image] =>[orig_patent_app_number] => 13140791
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/140791 | COUMARIN-BASED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND CANCER | Dec 20, 2009 | Abandoned |
Array
(
[id] => 7784686
[patent_doc_number] => 20120046242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY'
[patent_app_type] => utility
[patent_app_number] => 13/141838
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14147
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046242.pdf
[firstpage_image] =>[orig_patent_app_number] => 13141838
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141838 | MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY | Dec 20, 2009 | Abandoned |
Array
(
[id] => 9427717
[patent_doc_number] => 08703792
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'C-1 analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation'
[patent_app_type] => utility
[patent_app_number] => 13/140209
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16082
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140209
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/140209 | C-1 analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation | Dec 16, 2009 | Issued |
Array
(
[id] => 6267518
[patent_doc_number] => 20100298377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'NOVEL SUBSTITUTED INDAZOLES, THE PREPARATION THEREOF AND USE OF SAME IN THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 12/636357
[patent_app_country] => US
[patent_app_date] => 2009-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34840
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298377.pdf
[firstpage_image] =>[orig_patent_app_number] => 12636357
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/636357 | NOVEL SUBSTITUTED INDAZOLES, THE PREPARATION THEREOF AND USE OF SAME IN THERAPEUTICS | Dec 10, 2009 | Abandoned |
Array
(
[id] => 8968912
[patent_doc_number] => 08507724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-13
[patent_title] => 'Compounds for use in the treatment of pain'
[patent_app_type] => utility
[patent_app_number] => 13/133569
[patent_app_country] => US
[patent_app_date] => 2009-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 14461
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133569
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/133569 | Compounds for use in the treatment of pain | Dec 8, 2009 | Issued |
Array
(
[id] => 6212455
[patent_doc_number] => 20110135755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'Combination therapies for treating neoplastic disease'
[patent_app_type] => utility
[patent_app_number] => 12/654047
[patent_app_country] => US
[patent_app_date] => 2009-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6970
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20110135755.pdf
[firstpage_image] =>[orig_patent_app_number] => 12654047
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/654047 | Combination therapies for treating neoplastic disease | Dec 7, 2009 | Abandoned |
Array
(
[id] => 6353344
[patent_doc_number] => 20100086553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'ANTITUMOR AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/632182
[patent_app_country] => US
[patent_app_date] => 2009-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5080
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20100086553.pdf
[firstpage_image] =>[orig_patent_app_number] => 12632182
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/632182 | ANTITUMOR AGENT | Dec 6, 2009 | Abandoned |
Array
(
[id] => 7555523
[patent_doc_number] => 08067424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Selective inhibitors for cyclin-dependent kinases'
[patent_app_type] => utility
[patent_app_number] => 12/631373
[patent_app_country] => US
[patent_app_date] => 2009-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 46565
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067424.pdf
[firstpage_image] =>[orig_patent_app_number] => 12631373
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/631373 | Selective inhibitors for cyclin-dependent kinases | Dec 3, 2009 | Issued |
Array
(
[id] => 7581000
[patent_doc_number] => 20110294883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'ALPHA-DERIVATIVES OF CIS-MONOUNSATURATED FATTY ACIDS INTENDED FOR USE AS A DRUG'
[patent_app_type] => utility
[patent_app_number] => 13/132231
[patent_app_country] => US
[patent_app_date] => 2009-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 16399
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294883.pdf
[firstpage_image] =>[orig_patent_app_number] => 13132231
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/132231 | α-Derivatives of cis-monounsaturated fatty acids intended for use as a drug | Dec 3, 2009 | Issued |